HB1007 Summary

• Authorizes pharmacists to dispense HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) under statewide protocols, adding these to existing pharmacist-initiated therapies like naloxone and oral contraceptives.

• Requires pharmacists dispensing PrEP or PEP to complete board-approved training within 12 months covering financial assistance programs and federal guidelines, and mandates consultation (no patient waiver allowed).

• For PrEP dispensing: Pharmacists must verify negative HIV test within 7 days (antigen/antibody, antibody-only, or rapid test), dispense 30-60 day supplies, screen for acute infection symptoms and contraindicated medications, and provide counseling on side effects, pregnancy safety, adherence, and testing for HIV and other conditions.

• For PEP dispensing: Pharmacists must determine exposure occurred within 72 hours, verify patient meets clinical criteria, conduct or facilitate HIV testing, provide counseling on similar topics as PrEP, and document services in patient records shared with primary care providers.

• Prohibits pharmacy benefits managers from blocking pharmacists from dispensing PrEP or PEP, and prevents health insurers from requiring prior authorization or step therapy for antiretroviral drugs used for HIV prevention (though insurers may require such requirements if multiple FDA-approved equivalents exist).